Adam Scott Levy
CFO and Secretary · Mineralys Therapeutics, Inc.
- 2024
- Feb 21, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Adam Scott Levy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Taylor Slingsby - $46.36M in MLYS purchases and sales in the last 12 months
- Jon Congleton - $15.64M in MLYS purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $8.76M in MLYS purchases and sales in the last 12 months
- David Malcom Rodman - $4.88M in MLYS purchases and sales in the last 12 months
- Eric Warren - $3.30M in MLYS purchases and sales in the last 12 months
- Alexander M. Gold - $1.58M in MLYS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Adam Scott Levy?
Adam Scott Levy is a corporate insider, tracked as CFO and Secretary of Mineralys Therapeutics, Inc. (MLYS). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Adam Scott Levy last file a Form 4?
The most recent primary Form 4 on record is dated 21 February 2026, one of 6 filings going back to 2024.
Has Adam Scott Levy been buying or selling stock?
Recorded transactions: 0 open-market purchases and 17 open-market sales ($7.19M) across all tracked filings.
